You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (202)

Journals (0)

1-10 of 202 results for HER2 inhibitors

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Tyrosine Kinase Inhibitors in the Combination Therapy of HER2 Positive Breast Cancer

Open access

Review article

First published 2020

Tyrosine Kinase Inhibitors in the Combination Therapy of HER2 Positive Breast Cancer

Xue Yang, Dapeng Wu, Shengli Yuan

Technology in Cancer Research & Treatment

Select article: Lapatinib,a Dual-Targeted Small Molecule Inhibitor of EGFR and HER2,in HER2-Amplified Breast Cancer: From Bench to Bedside

Open access

Review article

First published 2011

Lapatinib,a Dual-Targeted Small Molecule Inhibitor of EGFR and HER2,in HER2-Amplified Breast Cancer: From Bench to Bedside

Roger Y. Tsang, Saeed Sadeghi, Richard S. Finn

Clinical Medicine Insights: Therapeutics

Select article: CDK4/6 inhibitors in breast cancer: beyond hormone receptor-positive HER2-negative disease

Open access

Review article

First published 2018

CDK4/6 inhibitors in breast cancer: beyond hormone receptor-positive HER2-negative disease

Adriana Matutino, Carla Amaro, Sunil Verma

Therapeutic Advances in Medical Oncology

Select article: Abemaciclib: The First FDA-Approved CDK4/6 Inhibitor for the Adjuvant Treatment of HR+ HER2− Early Breast Cancer

Retricted access

Review article

First published 2022-11

Abemaciclib: The First FDA-Approved CDK4/6 Inhibitor for the Adjuvant Treatment of HR+ HER2− Early Breast Cancer

Farah Raheem, Henry Ofori, Lacey Simpson [...]

Annals of Pharmacotherapy

Select article: Advances in the mechanism of CDK4/6 inhibitor resistance in HR+/HER2− breast cancer

Open access

Review article

First published 2024

Advances in the mechanism of CDK4/6 inhibitor resistance in HR+/HER2− breast cancer

Sijia Wu, Junnan Xu, Yiwen Ma [...]

Therapeutic Advances in Medical Oncology

Select article: First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for HER2 -altered NSCLC: a retrospective real-world POLISH study

Open access

Research article

First published 2022

First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for HER2 -altered NSCLC: a retrospective real-world POLISH study

Guangjian Yang, Yaning Yang, Runze Liu [...]

Therapeutic Advances in Medical Oncology

Select article: Exploring the Therapeutic Potential of Virtual Screened Novel HER2 Inhibitors via QSAR,Molecular Docking and Dynamics Simulations

Open access

Research article

First published 2025-10

Exploring the Therapeutic Potential of Virtual Screened Novel HER2 Inhibitors via QSAR,Molecular Docking and Dynamics Simulations

Khurram Rehman, Zoya Iqbal, Zhiqin Deng [...]

Dose-Response

Select article: HER2-positive breast cancer: new therapeutic frontiers and overcoming resistance

Open access

Review article

First published 2019

HER2-positive breast cancer: new therapeutic frontiers and overcoming resistance

Sonia Pernas, Sara M. Tolaney

Therapeutic Advances in Medical Oncology

Select article: Managing advanced HR-positive,HER2-negative breast cancer with CDK4/6 inhibitors in post-menopausal patients: is there a best sequence?

Open access

Editorial

First published 2018

Managing advanced HR-positive,HER2-negative breast cancer with CDK4/6 inhibitors in post-menopausal patients: is there a best sequence?

Lorenzo Rossi, Amelia McCartney, Emanuela Risi [...]

Therapeutic Advances in Medical Oncology

Select article: Updated Review Article: Cyclin-Dependent Kinase 4/6 Inhibitor Impact,FDA Approval,and Resistance Pathways

Retricted access

Review article

First published 2023-12

Updated Review Article: Cyclin-Dependent Kinase 4/6 Inhibitor Impact,FDA Approval,and Resistance Pathways

Rodney J. Hunter, Jooyoung Park, Kristen J. Asprer [...]

Journal of Pharmacy Technology

1
2
3
•••
21
10 / page

Article type

Publication date

Subjects

Access